𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dyslipoproteinemia in systemic lupus erythematosus: Effect of Corticosteroids

✍ Scribed by Walter H. Ettinger; Andrew P. Goldberg; Deborah Applebaum-Bowden; William R. Hazzard

Book ID
115681885
Publisher
Elsevier Science
Year
1987
Tongue
English
Weight
743 KB
Volume
83
Category
Article
ISSN
1555-7162

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Dyslipoproteinemia in pediatric systemic
Dyslipoproteinemia in pediatric systemic lupus erythematosus
✍ Norman T. Ilowite; Paul Samuel; Ellen Ginzler; Marc S. Jacobson πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 523 KB

Patients with systemic lupus erythematosus are at increased risk for premature atherosclerosis. We examined one possible etiologic factor, dyslipoproteinemia, both before and after corticosteroid therapy. We identified 2 distinct patterns of dyslipoproteinemia. One is attributable to active disease;

Corticosteroids and neuropsychological f
Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus
✍ Susan D. Denburg; Ramona M. Carbotte; Judah A. Denburg πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 1016 KB

This study was designed to assess the effects of corticosteroids on select aspects of nervous system functioning, specifically, cognition and mood, as well as disease-related symptoms in individual patients with mild systemic lupus erythematosus (SLE) and mild neuropsychiatric ( N P ) symptoms. Met